Jump to content

ESIZENSKY

Members
  • Content count

    75
  • Joined

  • Last visited

  • Country

    United States

About ESIZENSKY

  • Rank
    Junior Member
  • Birthday 06/09/1960

Contact Methods

  • Yahoo
    EVASIZENSKY@YAHOO.COM

Profile Information

  • Biography
    BLOOD BANK SUPERVISOR
  • Location
    SHELTON,CT
  • Occupation
    BLOOD BANK SUPERVISOR

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. ESIZENSKY

    Meditech Orders Inpatient vs Outpatient

    Do you manually enter the tested results into the inpatient order? Do you have a "copy" function that takes the outpatient results and copies it into the new inpatient.
  2. ESIZENSKY

    Blood Transportation to Floors

    clear plastic bags
  3. Couple questions: How do you manage outpatient and inpatient test orders? If you have an indated TS a new accession number is generated with a new visit account. Meditech generates a new accession number with each visit. Can you move the TS from the outpatient account to patient account to avoid a new TS sample. Moving account numbers in Meditech moves all tests associated with the accession number that creates more problems.
  4. We have Meditech and TAR and it is a problem. The transfusion report gives minimal information. My staff spends hours on auditing for compliance. TAR was suppose to eliminate incomplete transfusion charts, consent, vitals ,outcome. The implementation of TAR requires checking in EMR for transfusion data . IF the data is not present we have to search for documentation in the nursing notes. I would like a NPR report specific for TAR documentation. IF the information is not documented then it is an incomplete document. Unfortunately we do not have access to a NPR writer and Meditech has limited options. If you manage to get a transfusion report to please can you share it.
  5. Is there a computer work around to create an aliquot in Meditech without the aliquot (i.e A, B) adding to the DIN number? The IT card prints the DIN number with this aliquot "A". and it does not match the ISBT label. My protocol references the ISBT product code designates the aliquot (i.e AO) but an inspector indicated that this does not represent a closed system and the DIN number can not change. Looking for a protocol to address this issue?
  6. ESIZENSKY

    Procedure manuals

    Do you have a flow chart how to manage antibody identification process and dosage antibodies (Anti-M).
  7. The inspector was not happy with the A added to the DIN on the IT card and computer screen. I am going to check with my IS team to research that KB article reference by Bankergirl. It may solve the problem. I will also add Sgoertzen comment that the clinical staff can differentiates which aliquot is processed for transfusion.
  8. It is a closed system. The inspector said it was not clear that it was a closed system if the "A" is added to the din number. I showed her our process that it was a closed system. The blood aliquot directly into a pedi bag attached to the mother unit. The computer creates the suffix.
  9. I was sited by the CAP inspector for my aliquot label for on a neonate unit. Meditech adds a suffix of "A" to the aliquot. She indicated that she was not convince that it was a closed unit even though the ISBT product code contained the "AO". Is there a way to print an aliquot label in Meditech that does not attach the "A" suffix?
  10. ESIZENSKY

    FDA reportable Question

    I had a similar situation and did report
  11. ESIZENSKY

    Meditech 5.67 CS Product Issue

    Pheresis products with the same DIN number the product description is different for each unit. RBC-1 and RBC-2 for the container. I recently added the product code to the compatibility tag for my modified products to prevent labeling issues.
  12. ESIZENSKY

    Thank You!

    How was the test? Do you have any test questions for future takers?
  13. Thank you for the information. I think it is best capture in issue so its the final check that the product is label correctly? To avoid that FDA event... Did you build the CDS or Meditech?
  14. ESIZENSKY

    Elution Studies

    1. Positive DAT IGG within 3 mos transfusion, when we get a request for polybrene , neonate 2. Gamma Elukit 11 acid elution, , Lui Freeze for neonates 3. Capture solid phase, tube 4. Initial antibody screen cells, panel
  15. Is the CDS in Meditech built in processing component or at issue function?
×

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.